Redpoint Investment Management Pty LTD Biogen Inc. Transaction History

Redpoint Investment Management Pty LTD

  • $684 Million
  • Q3 2022

A detailed history of Redpoint Investment Management Pty LTD transactions in Biogen Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 4,187 shares of BIIB stock, worth $728,203. This represents 0.16% of its overall portfolio holdings.

Number of Shares
4,187
Previous 4,234 1.11%
Holding current value
$728,203
Previous $863,000 29.55%
% of portfolio
0.16%
Previous 0.1%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022
SELL
$194.69 - $268.46 $9,150 - $12,617
-47 Reduced 1.11%
4,187 $1.12 Million
Q4 2021

Jan 19, 2022
SELL
$223.92 - $287.77 $15,002 - $19,280
-67 Reduced 1.56%
4,234 $1.02 Million
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $29,147 - $38,012
-103 Reduced 2.34%
4,301 $1.22 Million
Q2 2021

Aug 05, 2021
SELL
$259.0 - $414.71 $22,015 - $35,250
-85 Reduced 1.89%
4,404 $1.53 Million
Q4 2020

Jan 13, 2021
SELL
$236.26 - $355.63 $89,070 - $134,072
-377 Reduced 7.75%
4,489 $1.1 Million
Q3 2020

Oct 09, 2020
SELL
$264.77 - $305.71 $2.51 Million - $2.9 Million
-9,475 Reduced 66.07%
4,866 $1.38 Million
Q2 2020

Jul 17, 2020
SELL
$258.66 - $342.55 $483,694 - $640,568
-1,870 Reduced 11.54%
14,341 $3.84 Million
Q1 2020

Apr 22, 2020
SELL
$268.85 - $341.04 $2.06 Million - $2.62 Million
-7,679 Reduced 32.14%
16,211 $5.13 Million
Q4 2019

Feb 25, 2020
SELL
$220.06 - $304.07 $225,781 - $311,975
-1,026 Reduced 4.12%
23,890 $7.09 Million
Q3 2019

Nov 26, 2019
BUY
$217.44 - $243.88 $670,367 - $751,882
3,083 Added 14.12%
24,916 $5.8 Million
Q2 2019

Aug 07, 2019
BUY
$219.29 - $241.72 $666,860 - $735,070
3,041 Added 16.18%
21,833 $5.11 Million
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $470,043 - $735,204
2,169 Added 13.05%
18,792 $4.44 Million
Q4 2018

Feb 05, 2019
SELL
$278.5 - $352.75 $970,851 - $1.23 Million
-3,486 Reduced 17.34%
16,623 $5 Million
Q3 2018

Nov 08, 2018
SELL
$293.51 - $383.83 $155,560 - $203,429
-530 Reduced 2.57%
20,109 $7.11 Million
Q2 2018

Aug 09, 2018
SELL
$257.52 - $306.91 $42,490 - $50,640
-165 Reduced 0.79%
20,639 $5.99 Million
Q1 2018

Aug 09, 2018
BUY
$260.13 - $367.91 $71,015 - $100,439
273 Added 1.33%
20,804 $5.7 Million
Q4 2017

Aug 09, 2018
BUY
$307.64 - $344.58 $6.32 Million - $7.07 Million
20,531
20,531 $6.54 Million

Others Institutions Holding BIIB

# of Institutions
1,016
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email